Evidence map›Paper›PMID 39148677›Full record

ReviewPeerJ2024

Potential role of

Ami Febriza, Fityatun Usman, Andi Ulfah Magefirah Rasyid, Hasta Handayani Idrus, Mohd Helmy Mokhtar

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in PeerJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ami FebrizaFaculty of Medicine and Health Sciences, Universitas Muhammadiyah Makassar, Makassar, South Sulawesi, Indonesia.ORCID 0000-0002-0283-1727
Fityatun UsmanFaculty of Medicine and Health Sciences, Universitas Muhammadiyah Makassar, Makassar, South Sulawesi, Indonesia.
Andi Ulfah Magefirah RasyidFaculty of Medicine and Health Sciences, Universitas Muhammadiyah Makassar, Makassar, South Sulawesi, Indonesia.
Hasta Handayani IdrusCenter for Biomedical Research, Research Organization for Health, National Research and Innovation Agency (BRIN), Cibinong Bogor, West Java, Indonesia.
Mohd Helmy MokhtarDepartement of Physiology, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.ORCID 0000-0002-7801-6358

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing problem of antibiotic resistance in bacteria leads to an urgent need for new antimicrobial agents. Alternative treatments for bacterial infections need to be explored to tackle this issue. Plant-based substances are emerging as promising options.

Indexed as

Anti-Bacterial AgentsBacterial InfectionsManilkaraPlant ExtractsAnimalsHumansAnti-Bacterial AgentsPlant ExtractsAntibacterialAntioxidantsInfectionManilkara zapota L

Identifiers

PMID39148677
PMCPMC11326428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.